As of 2025-07-19, the Relative Valuation of Rubius Therapeutics Inc (RUBY) is (85.37) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Rubius Therapeutics Inc based on Relative Valuation is -102958.6%.
The range of the Relative Valuation is (71.71) - (86.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.2x - 29.8x | 26.7x |
| Forward P/E multiples | 24.8x - 42.0x | 32.3x |
| Fair Price | (71.71) - (86.18) | (85.37) |
| Upside | -86501.3% - -103934.9% | -102958.6% |
| Date | P/E |